EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites

Mingzhe Zhu, Xue Wang, Kai Wang, Zhiqiang Zhao, Yanqi Dang, Guang Ji, Fenghua Li, Wenjun Zhou

Frontiers in Cellular and Infection Microbiology · 2023

DOI: 10.3389/fcimb.2023.1066053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Mingzhe Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Digestive Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Non-alcoholic Fatty Liver Disease, Tandem Mass Spectrometry. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lingguizhugan decoction is a traditional Chinese medicine prescription that has been used to improve non-alcoholic fatty liver disease and its progressive form, non-alcoholic steatohepatitis (NASH). However, the anti-NASH effects and underlying mechanisms of Lingguizhugan decoction remain unclear.

Methods

Male Sprague-Dawley rats were fed a methionine- and choline-deficient (MCD) diet to induce NASH, and then given Lingguizhugan decoction orally for four weeks. NASH indexes were evaluated by histopathological analysis and biochemical parameters including serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), liver triglycerides (TG), etc. Fecal samples of rats were subjected to profile the changes of gut microbiota and metabolites using 16S rRNA sequencing and ultra-performance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS). Bioinformatics was used to identify Lingguizhugan decoction reversed candidates, and Spearman’s correlation analysis was performed to uncover the relationship among gut microbiota, fecal metabolites, and NASH indexes.

Results

Four-week Lingguizhugan decoction treatment ameliorated MCD diet-induced NASH features, as evidenced by improved hepatic steatosis and inflammation, as well as decreased serum AST and ALT levels. Besides, Lingguizhugan decoction partially restored the changes in gut microbial community composition in NASH rats. Meanwhile, the relative abundance of 26 genera was significantly changed in NASH rats, and 11 genera (such as odoribacter, Ruminococcus_1 , Ruminococcaceae_UCG-004, etc. ) were identified as significantly reversed by Lingguizhugan decoction. Additionally, a total of 99 metabolites were significantly altered in NASH rats, and 57 metabolites (such as TDCA, Glutamic acid, Isocaproic acid, etc. ) enriched in different pathways were reversed by Lingguizhugan decoction. Furthermore, Spearman’s correlation analyses revealed that most of the 57 metabolites were significantly correlated with 11 genera and NASH indexes.

Conclusion

Lingguizhugan decoction may exert protective effects on NASH partially by modulating gut microbiota and correlated metabolites.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeNon-alcoholic Fatty Liver DiseaseTandem Mass SpectrometryAnimalsMaleMiceRatsCholineChromatography, LiquidLiverMice, Inbred C57BLRats, Sprague-DawleyRNA, Ribosomal, 16SDrugs, Chinese Herbal

Stichwörter der Autor:innen

Lingguizhugan decoctionMCD dietNASHgut microbiotametabolomics

Substanzen

CholineRNA, Ribosomal, 16SDrugs, Chinese Herbal

Autor:innen und Institutionen

  • Institute of Digestive Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • School of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Experiment Center for Science and Technology, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Zitieren

APA

Zhu, M., Wang, X., Wang, K., Zhao, Z., Dang, Y., Ji, G., Li, F., & Zhou, W. (2023). Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1066053

Vancouver

Zhu M, Wang X, Wang K, Zhao Z, Dang Y, Ji G, et al. Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1066053

BibTeX
@article{Zhu2023,
  author = {Zhu, Mingzhe and Wang, Xue and Wang, Kai and Zhao, Zhiqiang and Dang, Yanqi and Ji, Guang and Li, Fenghua and Zhou, Wenjun},
  title = {Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  doi = {10.3389/fcimb.2023.1066053}
}
Kostenlos starten →